APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-Infectives

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Anti-Infectives Market Outlook and Growth Opportunities 2026

26 December 2025198 pages

Choose your research edition.

Industry ResearchAnti-Infectives Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-Infectives Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Anti-Infectives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-Infectives Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-Infectives Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Anti-Infectives market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Anti-Infectives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anti-Infectives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-Infectives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Anti-Infectives market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Anti-Infectives market include Astra Zeneca plc, Glaxo SmithKline plc, Novartis, Wockhardt ltd, Pfizer, Roche, Merck, Johnson & Johnson and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Anti-Infectives market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anti-Infectives and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anti-Infectives sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anti-Infectives market size, projected growth trends, production technologies, key applications, and end-use industries.

Anti-Infectives Segment by Company

Astra Zeneca plc

Glaxo SmithKline plc

Novartis

Wockhardt ltd

Pfizer

Roche

Merck

Johnson & Johnson

Sanofi

Anti-Infectives Segment by Type

Antifungal

Antibacterial

Antiviral

Anti-Infectives Segment by Application

Retail Pharmacies

Mail Order Pharmacies

Hospital Pharmacies

Anti-Infectives Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Anti-Infectives status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Anti-Infectives market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Anti-Infectives significant trends, drivers, influence factors in global and regions.

6. To analyze Anti-Infectives competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Infectives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-Infectives and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Infectives.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Anti-Infectives market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Anti-Infectives industry.

Chapter 3: Detailed analysis of Anti-Infectives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Anti-Infectives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Anti-Infectives in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Anti-Infectives Industry Trends Table 2. Anti-Infectives Industry Drivers Table 3. Anti-Infectives Industry Opportunities and Challenges Table 4. Anti-Infectives Industry Restraints Table 5. Global Anti-Infectives Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Anti-Infectives Revenue Share by Company (2021-2026) Table 7. Global Anti-Infectives Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Anti-Infectives Sales Volume Share by Company (2021-2026) Table 9. Global Anti-Infectives Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Anti-Infectives Company Ranking, (2024-2026) & (USD Million) Table 11. Global Anti-Infectives Key Company Manufacturing Base & Headquarters Table 12. Global Anti-Infectives Company, Product Type & Application Table 13. Global Anti-Infectives Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Anti-Infectives by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Antifungal Table 18. Significant Companies of Antibacterial Table 19. Significant Companies of Antiviral Table 20. Global Anti-Infectives Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 21. Global Anti-Infectives Sales Volume by Type (2021-2026) & (W Units) Table 22. Global Anti-Infectives Sales Volume by Type (2027-2032) & (W Units) Table 23. Global Anti-Infectives Sales Volume Share by Type (2021-2026) Table 24. Global Anti-Infectives Sales Volume Share by Type (2027-2032) Table 25. Global Anti-Infectives Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Anti-Infectives Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Anti-Infectives Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Anti-Infectives Sales Value Share by Type (2021-2026) Table 29. Global Anti-Infectives Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Retail Pharmacies Table 31. Significant Companies of Mail Order Pharmacies Table 32. Significant Companies of Hospital Pharmacies Table 33. Global Anti-Infectives Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 34. Global Anti-Infectives Sales Volume by Application (2021-2026) & (W Units) Table 35. Global Anti-Infectives Sales Volume by Application (2027-2032) & (W Units) Table 36. Global Anti-Infectives Sales Volume Share by Application (2021-2026) Table 37. Global Anti-Infectives Sales Volume Share by Application (2027-2032) Table 38. Global Anti-Infectives Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Anti-Infectives Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Anti-Infectives Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Anti-Infectives Sales Value Share by Application (2021-2026) Table 42. Global Anti-Infectives Sales Value Share by Application (2027-2032) Table 43. Global Anti-Infectives Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 44. Global Anti-Infectives Sales by Region (2021-2026) & (W Units) Table 45. Global Anti-Infectives Sales Market Share by Region (2021-2026) Table 46. Global Anti-Infectives Sales by Region (2027-2032) & (W Units) Table 47. Global Anti-Infectives Sales Market Share by Region (2027-2032) Table 48. Global Anti-Infectives Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Anti-Infectives Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Anti-Infectives Sales Value Share by Region (2021-2026) Table 51. Global Anti-Infectives Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Anti-Infectives Sales Value Share by Region (2027-2032) Table 53. Global Anti-Infectives Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Anti-Infectives Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Anti-Infectives Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 56. Global Anti-Infectives Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Anti-Infectives Sales by Country (2021-2026) & (W Units) Table 58. Global Anti-Infectives Sales Market Share by Country (2021-2026) Table 59. Global Anti-Infectives Sales by Country (2027-2032) & (W Units) Table 60. Global Anti-Infectives Sales Market Share by Country (2027-2032) Table 61. Global Anti-Infectives Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Anti-Infectives Sales Value Market Share by Country (2021-2026) Table 63. Global Anti-Infectives Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Anti-Infectives Sales Value Market Share by Country (2027-2032) Table 65. Astra Zeneca plc Company Information Table 66. Astra Zeneca plc Business Overview Table 67. Astra Zeneca plc Anti-Infectives Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Astra Zeneca plc Anti-Infectives Product Portfolio Table 69. Astra Zeneca plc Recent Development Table 70. Glaxo SmithKline plc Company Information Table 71. Glaxo SmithKline plc Business Overview Table 72. Glaxo SmithKline plc Anti-Infectives Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Glaxo SmithKline plc Anti-Infectives Product Portfolio Table 74. Glaxo SmithKline plc Recent Development Table 75. Novartis Company Information Table 76. Novartis Business Overview Table 77. Novartis Anti-Infectives Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Novartis Anti-Infectives Product Portfolio Table 79. Novartis Recent Development Table 80. Wockhardt ltd Company Information Table 81. Wockhardt ltd Business Overview Table 82. Wockhardt ltd Anti-Infectives Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Wockhardt ltd Anti-Infectives Product Portfolio Table 84. Wockhardt ltd Recent Development Table 85. Pfizer Company Information Table 86. Pfizer Business Overview Table 87. Pfizer Anti-Infectives Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Pfizer Anti-Infectives Product Portfolio Table 89. Pfizer Recent Development Table 90. Roche Company Information Table 91. Roche Business Overview Table 92. Roche Anti-Infectives Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Roche Anti-Infectives Product Portfolio Table 94. Roche Recent Development Table 95. Merck Company Information Table 96. Merck Business Overview Table 97. Merck Anti-Infectives Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Merck Anti-Infectives Product Portfolio Table 99. Merck Recent Development Table 100. Johnson & Johnson Company Information Table 101. Johnson & Johnson Business Overview Table 102. Johnson & Johnson Anti-Infectives Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Johnson & Johnson Anti-Infectives Product Portfolio Table 104. Johnson & Johnson Recent Development Table 105. Sanofi Company Information Table 106. Sanofi Business Overview Table 107. Sanofi Anti-Infectives Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Sanofi Anti-Infectives Product Portfolio Table 109. Sanofi Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. Anti-Infectives Distributors List Table 113. Anti-Infectives Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Anti-Infectives Product Image Figure 2. Global Anti-Infectives Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-Infectives Sales Value (2021-2032) & (US$ Million) Figure 4. Global Anti-Infectives Sales (2021-2032) & (W Units) Figure 5. Global Anti-Infectives Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Anti-Infectives Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Antifungal Image Figure 10. Antibacterial Image Figure 11. Antiviral Image Figure 12. Global Anti-Infectives Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 13. Global Anti-Infectives Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Anti-Infectives Sales Volume Share by Type (2021-2032) Figure 15. Global Anti-Infectives Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Anti-Infectives Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Anti-Infectives Sales Value Share by Type (2021-2032) Figure 18. Retail Pharmacies Image Figure 19. Mail Order Pharmacies Image Figure 20. Hospital Pharmacies Image Figure 21. Global Anti-Infectives Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 22. Global Anti-Infectives Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Anti-Infectives Sales Volume Share by Application (2021-2032) Figure 24. Global Anti-Infectives Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Anti-Infectives Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Anti-Infectives Sales Value Share by Application (2021-2032) Figure 27. Global Anti-Infectives Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 28. Global Anti-Infectives Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Anti-Infectives Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Anti-Infectives Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Anti-Infectives Sales Value (2021-2032) & (US$ Million) Figure 32. North America Anti-Infectives Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Anti-Infectives Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Anti-Infectives Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Anti-Infectives Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Anti-Infectives Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Anti-Infectives Sales Value (2021-2032) & (US$ Million) Figure 38. South America Anti-Infectives Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Anti-Infectives Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Anti-Infectives Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Anti-Infectives Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Anti-Infectives Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Antifungal
  • Antibacterial
  • Antiviral
Applications
  • Retail Pharmacies
  • Mail Order Pharmacies
  • Hospital Pharmacies
Companies covered
  • Astra Zeneca plc
  • Glaxo SmithKline plc
  • Novartis
  • Wockhardt ltd
  • Pfizer
  • Roche
  • Merck
  • Johnson & Johnson
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anti-Infectives Sales Value (2021-2032)
  4. 1.2.2 Global Anti-Infectives Sales Volume (2021-2032)
  5. 1.2.3 Global Anti-Infectives Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Anti-Infectives Market Dynamics
  1. 2.1 Anti-Infectives Industry Trends
  2. 2.2 Anti-Infectives Industry Drivers
  3. 2.3 Anti-Infectives Industry Opportunities and Challenges
  4. 2.4 Anti-Infectives Industry Restraints
3 Anti-Infectives Market by Company
  1. 3.1 Global Anti-Infectives Company Revenue Ranking in 2025
  2. 3.2 Global Anti-Infectives Revenue by Company (2021-2026)
  3. 3.3 Global Anti-Infectives Sales Volume by Company (2021-2026)
  4. 3.4 Global Anti-Infectives Average Price by Company (2021-2026)
  5. 3.5 Global Anti-Infectives Company Ranking (2024-2026)
  6. 3.6 Global Anti-Infectives Company Manufacturing Base and Headquarters
  7. 3.7 Global Anti-Infectives Company Product Type and Application
  8. 3.8 Global Anti-Infectives Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Anti-Infectives Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Anti-Infectives Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Anti-Infectives Market by Type
  1. 4.1 Anti-Infectives Type Introduction
  2. 4.1.1 Antifungal
  3. 4.1.2 Antibacterial
  4. 4.1.3 Antiviral
  5. 4.2 Global Anti-Infectives Sales Volume by Type
  6. 4.2.1 Global Anti-Infectives Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Anti-Infectives Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Anti-Infectives Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Anti-Infectives Sales Value by Type
  10. 4.3.1 Global Anti-Infectives Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Anti-Infectives Sales Value by Type (2021-2032)
  12. 4.3.3 Global Anti-Infectives Sales Value Share by Type (2021-2032)
5 Anti-Infectives Market by Application
  1. 5.1 Anti-Infectives Application Introduction
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Mail Order Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Anti-Infectives Sales Volume by Application
  6. 5.2.1 Global Anti-Infectives Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Anti-Infectives Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Anti-Infectives Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Anti-Infectives Sales Value by Application
  10. 5.3.1 Global Anti-Infectives Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Anti-Infectives Sales Value by Application (2021-2032)
  12. 5.3.3 Global Anti-Infectives Sales Value Share by Application (2021-2032)
6 Anti-Infectives Regional Sales and Value Analysis
  1. 6.1 Global Anti-Infectives Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anti-Infectives Sales by Region (2021-2032)
  3. 6.2.1 Global Anti-Infectives Sales by Region: 2021-2026
  4. 6.2.2 Global Anti-Infectives Sales by Region (2027-2032)
  5. 6.3 Global Anti-Infectives Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Anti-Infectives Sales Value by Region (2021-2032)
  7. 6.4.1 Global Anti-Infectives Sales Value by Region: 2021-2026
  8. 6.4.2 Global Anti-Infectives Sales Value by Region (2027-2032)
  9. 6.5 Global Anti-Infectives Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Anti-Infectives Sales Value (2021-2032)
  12. 6.6.2 North America Anti-Infectives Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Anti-Infectives Sales Value (2021-2032)
  15. 6.7.2 Europe Anti-Infectives Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Anti-Infectives Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Anti-Infectives Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Anti-Infectives Sales Value (2021-2032)
  21. 6.9.2 South America Anti-Infectives Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Anti-Infectives Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Anti-Infectives Sales Value Share by Country, 2025 VS 2032
7 Anti-Infectives Country-level Sales and Value Analysis
  1. 7.1 Global Anti-Infectives Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Anti-Infectives Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Anti-Infectives Sales by Country (2021-2032)
  4. 7.3.1 Global Anti-Infectives Sales by Country (2021-2026)
  5. 7.3.2 Global Anti-Infectives Sales by Country (2027-2032)
  6. 7.4 Global Anti-Infectives Sales Value by Country (2021-2032)
  7. 7.4.1 Global Anti-Infectives Sales Value by Country (2021-2026)
  8. 7.4.2 Global Anti-Infectives Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Anti-Infectives Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Anti-Infectives Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Anti-Infectives Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Anti-Infectives Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Anti-Infectives Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Anti-Infectives Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Anti-Infectives Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Anti-Infectives Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Anti-Infectives Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Anti-Infectives Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Anti-Infectives Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Anti-Infectives Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Anti-Infectives Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Anti-Infectives Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Anti-Infectives Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Anti-Infectives Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Anti-Infectives Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Anti-Infectives Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Anti-Infectives Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Anti-Infectives Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Anti-Infectives Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Anti-Infectives Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Anti-Infectives Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Anti-Infectives Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Anti-Infectives Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Anti-Infectives Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Anti-Infectives Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Anti-Infectives Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Anti-Infectives Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Astra Zeneca plc
  2. 8.1.1 Astra Zeneca plc Company Information
  3. 8.1.2 Astra Zeneca plc Business Overview
  4. 8.1.3 Astra Zeneca plc Anti-Infectives Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Astra Zeneca plc Anti-Infectives Product Portfolio
  6. 8.1.5 Astra Zeneca plc Recent Developments
  7. 8.2 Glaxo SmithKline plc
  8. 8.2.1 Glaxo SmithKline plc Company Information
  9. 8.2.2 Glaxo SmithKline plc Business Overview
  10. 8.2.3 Glaxo SmithKline plc Anti-Infectives Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Glaxo SmithKline plc Anti-Infectives Product Portfolio
  12. 8.2.5 Glaxo SmithKline plc Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Anti-Infectives Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Anti-Infectives Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Wockhardt ltd
  20. 8.4.1 Wockhardt ltd Company Information
  21. 8.4.2 Wockhardt ltd Business Overview
  22. 8.4.3 Wockhardt ltd Anti-Infectives Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Wockhardt ltd Anti-Infectives Product Portfolio
  24. 8.4.5 Wockhardt ltd Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Anti-Infectives Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Anti-Infectives Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Roche
  32. 8.6.1 Roche Company Information
  33. 8.6.2 Roche Business Overview
  34. 8.6.3 Roche Anti-Infectives Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Roche Anti-Infectives Product Portfolio
  36. 8.6.5 Roche Recent Developments
  37. 8.7 Merck
  38. 8.7.1 Merck Company Information
  39. 8.7.2 Merck Business Overview
  40. 8.7.3 Merck Anti-Infectives Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Merck Anti-Infectives Product Portfolio
  42. 8.7.5 Merck Recent Developments
  43. 8.8 Johnson & Johnson
  44. 8.8.1 Johnson & Johnson Company Information
  45. 8.8.2 Johnson & Johnson Business Overview
  46. 8.8.3 Johnson & Johnson Anti-Infectives Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Johnson & Johnson Anti-Infectives Product Portfolio
  48. 8.8.5 Johnson & Johnson Recent Developments
  49. 8.9 Sanofi
  50. 8.9.1 Sanofi Company Information
  51. 8.9.2 Sanofi Business Overview
  52. 8.9.3 Sanofi Anti-Infectives Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Sanofi Anti-Infectives Product Portfolio
  54. 8.9.5 Sanofi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Anti-Infectives Value Chain Analysis
  2. 9.1.1 Anti-Infectives Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Anti-Infectives Sales Mode & Process
  6. 9.2 Anti-Infectives Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Anti-Infectives Distributors
  9. 9.2.3 Anti-Infectives Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst